Immunomedics eyes Australia for LeukoScan

Pharmaceutical firm Immunomedics will bring its LeukoScan contrast agent to Australia. The Australian Drug Evaluation Committee has recommended approval for imaging of suspected osteomyelitis in long bones and feet, including those with diabetic foot ulcers, according to the Morris Plains, NJ-based vendor. Immunomedics partner Australian Radioisotopes will handle marketing and distribution.

By AuntMinnie.com staff writers
March 7, 2002

Related Reading

Immunomedics doubles revenue, trims loss, November 9, 2001

Immunomedics licenses labeling method, October 29, 2001

Immunomedics trims loss in 2001, August 8, 2001

Immunomedics appoints Sullivan CEO, March 21, 2001

Copyright © 2002 AuntMinnie.com

Page 1 of 3619
Next Page